Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular renal sympathetic denervation versus spironolactone for treatment-resistant hypertension
2011-004995-13Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of spironolactone in hypertension (HTN) (2 arms), sponsored by Erasmus MC. Started Dec 2011; status: active.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2011-004995-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004995-13.